Wart Clinical Trial
— MAGNETIKOfficial title:
Effect of the Intervention of Biofields Therapy on Warts of the Hands and Feet in Adults: a Prospective, Randomized, Double-blind Trial
NCT number | NCT02773719 |
Other study ID # | 15-163 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2016 |
Est. completion date | November 2018 |
Verified date | April 2016 |
Source | University Hospital, Caen |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Traditionally, healers are willing to look after, two out of three French citizens have
already appealed to them at least once during their lives. Many healers in good faith are
exercising their magnetism as a "gift" often inherited from elders. Now, they create interest
of doctors who do not hesitate in some cases to ensure their cooperation, to implicitly
recognize their mysterious talents. Some serious studies have examined these practices:
Several studies have been conducted on the influence of biofield therapies in pain,
depression and fatigue in cancer disease. The investigators propose a study of the effect of
magnetism on the wart disease whose cure is objectively assessable.
Sixty-two subjects in total would be included, comparing 2 proportions observed: the
proportion of healing in the group treated with a "real" biofield therapist (recognized and
affiliated to the National Group for Alternative Medicine in France) to the proportion of
healing in the group treated with a "fake" biofield therapist (someone assessed as not having
capacity to magnetize). The "fake" biofield therapist, placebo, has been trained to replicate
gestures during a training validated by an independent recognized biofield therapist.
Status | Completed |
Enrollment | 62 |
Est. completion date | November 2018 |
Est. primary completion date | November 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Patients with common warts on hands or feet for over at least 3 months are eligible for the
study. Patients fulfilling one or more of the following criteria will not be included: lack
of informed consent prior to randomization, younger than 18 years or under judicial
protection, treated with oral corticotherapy for more than 6 months, immunosuppressed or
with history of transplant surgery, undergoing chemotherapy or suspected to have
carcinomatous warts, or patients with infected warts, injured warts or already treated
within 90 days with chemical processing, medical device, surgery or ever treated with
biofield therapy. Subject will be excluded from the study if its warts was treated by other treatment during protocol. - ulcerated wart - cancerous wart |
Country | Name | City | State |
---|---|---|---|
France | Caen University Hospital | Caen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | disappearance of a common palmar or plantar wart | week 3 | ||
Secondary | disappearance of each other wart than the original one 3 weeks after the therapy | week 3 | ||
Secondary | Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3 | week3 | ||
Secondary | Percentage of reduction of each wart will be calculated using mean diameter of each wart at W0 and W3 | week 3 | ||
Secondary | Disappearance of warts at 6 weeks | week 6 | ||
Secondary | Level of belief in biofield therapy of the subject | week 0 | week 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00328991 -
Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts
|
N/A |